Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

GJG Capital, LLC — Matinas BioPharma Holdings, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / GJG Capital, LLC

GJG Capital, LLC

10% owner at Matinas BioPharma Holdings, Inc. · on record since Mar 16, 2017
Shareholder at Matinas BioPharma Holdings, Inc. · on record since Jul 3, 2017

Insider trading activity of GJG Capital, LLC

Transactions on record: 2; since Jul 3, 2017

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jul 3, 2017

Figures computed from official regulatory filings — methodology.

Companies where GJG Capital, LLC has traded

Matinas BioPharma Holdings, Inc.2 tx · Jul 3, 2017

Track record of GJG Capital, LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of GJG Capital, LLC

Co-insiders of GJG Capital, LLC

CONRAD HERBERT JMatinas BioPharma Holdings, Inc.
Corzo Kathryn PenkusMatinas BioPharma Holdings, Inc.
D An EvelynMatinas BioPharma Holdings, Inc.
DiPaolo DominickMatinas BioPharma Holdings, Inc.
EIDE ROBERT JMatinas BioPharma Holdings, Inc.
Ende Eric JMatinas BioPharma Holdings, Inc.
Fawzy Abdel A.Matinas BioPharma Holdings, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Ferguson James J. IIIMatinas BioPharma Holdings, Inc.

FERRARI STEFANOMatinas BioPharma Holdings, Inc.

Gaglione GaryMatinas BioPharma Holdings, Inc.

Giordano NatashaMatinas BioPharma Holdings, Inc.

GJG Life Sciences, LLCMatinas BioPharma Holdings, Inc.

Hoover ThomasMatinas BioPharma Holdings, Inc.

Hui LiuMatinas BioPharma Holdings, Inc.

Jabbour Jerome DMatinas BioPharma Holdings, Inc.

Kling Douglas FMatinas BioPharma Holdings, Inc.

Kucinski Keith AMatinas BioPharma Holdings, Inc.

LEPORE PATRICK GMatinas BioPharma Holdings, Inc.

Lorenzo JenniferMatinas BioPharma Holdings, Inc.

MANNINO RAPHAEL JMatinas BioPharma Holdings, Inc.

Matkovits TheresaMatinas BioPharma Holdings, Inc.

Murphy KeithMatinas BioPharma Holdings, Inc.

NEUGEBOREN EDWARDMatinas BioPharma Holdings, Inc.

Pembroke & Partners LLCMatinas BioPharma Holdings, Inc.

Rongen RoelofMatinas BioPharma Holdings, Inc.

Sanitam Partners LLCMatinas BioPharma Holdings, Inc.

Scibetta James SMatinas BioPharma Holdings, Inc.

Smith Robin LMatinas BioPharma Holdings, Inc.

STERN ADAM KMatinas BioPharma Holdings, Inc.

WIKLER MATTHEWMatinas BioPharma Holdings, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Matinas BioPharma Holdings, Inc.	Jul 3, 2017	Other	1,565,333	0.00 USD	$0	SEC
Matinas BioPharma Holdings, Inc.	Jul 3, 2017	Other	-10,496,760	0.00 USD	$0	SEC